New patent for United Therap drug TYVASO

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for TYVASO
Annual Drug Patent Expirations for TYVASO

Tyvaso is a drug marketed by United Therap and is included in two NDAs. It is available from one supplier. There are eleven patents protecting this drug and one Paragraph IV challenge.

Drug patent litigation for TYVASO.

This drug has thirty-five patent family members in nine countries.

The generic ingredient in TYVASO is treprostinil. One supplier is listed for this compound. Additional details are available on the treprostinil profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top